Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

TG Therapeutics Inc. (TGTX)

21.84   0.85 (4.05%) 05-22 16:00
Open: 20.94 Pre. Close: 20.99
High: 21.89 Low: 20.58
Volume: 1,420,968 Market Cap: 2,505M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 21.916 - 22.001 22.001 - 22.085
Low: 20.346 - 20.444 20.444 - 20.541
Close: 21.676 - 21.832 21.832 - 21.988

Technical analysis

as of: 2020-05-24 6:52:26 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 25.57     One year: 29.86
Support: Support1: 15.05    Support2: 10.83
Resistance: Resistance1: 21.89    Resistance2: 25.57
Pivot: 19.21
Moving Average: MA(5): 20.47     MA(20): 17.39
MA(100): 13.26     MA(250): 9.65
MACD: MACD(12,26): 2.38     Signal(9): 2.21
Stochastic oscillator: %K(14,3): 95.63     %D(3): 88.83
RSI: RSI(14): 71.62
52-week: High: 21.89  Low: 4.95  Change(%): 212.9
Average Vol(K): 3-Month: 243098  10-Days: 274724

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
TGTX has closed below upper band by 19.5%. Bollinger Bands are 60.6% wider than normal. The large width of the bands suggest high volatility as compared to TGTX's normal range. The bands have been in this wide range for 12 bars. This is a sign that the current trend might continue.

Headline News

Wed, 06 May 2020
TG Therapeutics Raises Approximately $60 Million in Gross Proceeds Through its At-the-Market Facility - GlobeNewswire

Thu, 14 May 2020
TG Therapeutics Announces Data Presentations at Upcoming Medical Meetings - GlobeNewswire

Thu, 14 May 2020
TG Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewswire

Mon, 11 May 2020
Were Hedge Funds Right About TG Therapeutics Inc (TGTX)? - Yahoo Finance

Mon, 11 May 2020
TG Therapeutics Provides Business Update and Reports First Quarter 2020 Financial Results - GlobeNewswire

Wed, 06 May 2020
Should You Worry About TG Therapeutics, Inc.'s (NASDAQ:TGTX) CEO Pay? - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 115
Shares Float (M) 86
% Held by Insiders 9.91
% Held by Institutions 57.47
Shares Short (K) 12,640
Shares Short P. Month (K) 12,500

Stock Financials

EPS -2.000
EPS Est This Year -1.840
EPS Est Next Year -1.640
Book Value (p.s.) -0.010
Profit Margin
Operating Margin -121454.60
Return on Assets (ttm) -105.2
Return on Equity (ttm) -2109.7
Qtrly Rev. Growth
Gross Profit (p.s.) 0.001
Sales Per Share 0.001
EBITDA (p.s.) -1.609
Qtrly Earnings Growth
Operating Cash Flow (M) -162
Levered Free Cash Flow (M) -93

Stock Valuations

PE Ratio -10.92
PEG Ratio
Price to Book value -2184.00
Price to Sales 16480.58
Price to Cash Flow -15.50

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.